These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 2515013)

  • 1. Peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) produce reduced levels of interleukin-4, interleukin-2 and interferon-gamma, but proliferate normally upon activation by mitogens.
    Pastorelli G; Roncarolo MG; Touraine JL; Peronne G; Tovo PA; de Vries JE
    Clin Exp Immunol; 1989 Dec; 78(3):334-40. PubMed ID: 2515013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Interleukin-4 suppresses immunoglobulin production by peripheral blood lymphocytes of patients with common variable immunodeficiency (CVI) induced by supernatants of T cell clones.
    Pastorelli G; Roncarolo MG; Touraine JL; Rousset F; Pene J; de Vries JE
    Clin Exp Immunol; 1989 Dec; 78(3):341-7. PubMed ID: 2575470
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous production of IL-2, IL-4, and IFN-gamma by activated human CD4+ and CD8+ T cell clones.
    Paliard X; de Waal Malefijt R; Yssel H; Blanchard D; Chrétien I; Abrams J; de Vries J; Spits H
    J Immunol; 1988 Aug; 141(3):849-55. PubMed ID: 2969394
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Abnormalities of lymphokine gene expression in patients with common variable immunodeficiency.
    Sneller MC; Strober W
    J Immunol; 1990 May; 144(10):3762-9. PubMed ID: 2110212
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes.
    Andersson U; Andersson J; Lindfors A; Wagner K; Möller G; Heusser CH
    Eur J Immunol; 1990 Jul; 20(7):1591-6. PubMed ID: 2117537
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Interleukin 2 enhances the natural killer cell activity of acquired immunodeficiency syndrome patients through a gamma-interferon-independent mechanism.
    Rook AH; Hooks JJ; Quinnan GV; Lane HC; Manischewitz JF; Macher AM; Masur H; Fauci AS; Djeu JY
    J Immunol; 1985 Mar; 134(3):1503-7. PubMed ID: 3918102
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dissociation in the production of B cell-stimulating factors (BCGF and BCDF) and interleukin 2 by T cells from a common variable immunodeficient patient.
    Saiki O; Shimizu M; Saeki Y; Kishimoto S; Kishimoto T
    J Immunol; 1984 Oct; 133(4):1920-4. PubMed ID: 6088629
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Regulation of IFN-gamma induction in human peripheral blood cells by exogenous and endogenously produced interleukin 2.
    Vilcek J; Henriksen-Destefano D; Siegel D; Klion A; Robb RJ; Le J
    J Immunol; 1985 Sep; 135(3):1851-6. PubMed ID: 3926889
    [TBL] [Abstract][Full Text] [Related]  

  • 9. IgE production by normal human B cells induced by alloreactive T cell clones is mediated by IL-4 and suppressed by IFN-gamma.
    Pène J; Rousset F; Brière F; Chrétien I; Paliard X; Banchereau J; Spits H; De Vries JE
    J Immunol; 1988 Aug; 141(4):1218-24. PubMed ID: 3135324
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dissociated production of interleukin-2 and immune (gamma) interferon by phytohaemagglutinin stimulated lymphocytes in healthy infants.
    Miyawaki T; Seki H; Taga K; Sato H; Taniguchi N
    Clin Exp Immunol; 1985 Feb; 59(2):505-11. PubMed ID: 3919982
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allergen-stimulated interleukin-4 and interferon-gamma production in primary culture: responses of subjects with allergic rhinitis and normal controls.
    Imada M; Simons FE; Jay FT; Hayglass KT
    Immunology; 1995 Jul; 85(3):373-80. PubMed ID: 7558124
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of lymphokines after Epstein Barr virus infection in vitro. I. Sources of and kinetics of production of interferons and interleukins in normal humans.
    Lotz M; Tsoukas CD; Fong S; Dinarello CA; Carson DA; Vaughan JH
    J Immunol; 1986 May; 136(10):3636-42. PubMed ID: 3009608
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumor-induced dysfunction in interleukin-2 production and interleukin-2 receptor signaling: a mechanism of immune escape.
    Rayman P; Uzzo RG; Kolenko V; Bloom T; Cathcart MK; Molto L; Novick AC; Bukowski RM; Hamilton T; Finke JH
    Cancer J Sci Am; 2000 Feb; 6 Suppl 1():S81-7. PubMed ID: 10685665
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Disparate CD4+ lamina propria (LP) lymphokine secretion profiles in inflammatory bowel disease. Crohn's disease LP cells manifest increased secretion of IFN-gamma, whereas ulcerative colitis LP cells manifest increased secretion of IL-5.
    Fuss IJ; Neurath M; Boirivant M; Klein JS; de la Motte C; Strong SA; Fiocchi C; Strober W
    J Immunol; 1996 Aug; 157(3):1261-70. PubMed ID: 8757634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Down-regulating effects of IL-4 and IL-10 on the IFN-gamma response in atopic dermatitis.
    Lester MR; Hofer MF; Gately M; Trumble A; Leung DY
    J Immunol; 1995 Jun; 154(11):6174-81. PubMed ID: 7751657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of interleukin 2 in inducing Ig production in a pokeweed mitogen-stimulated mononuclear cell system.
    Nakagawa N; Nakagawa T; Volkman DJ; Ambrus JL; Fauci AS
    J Immunol; 1987 Feb; 138(3):795-801. PubMed ID: 3100616
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Dermatophagoides-induced interleukin-10 production by peripheral blood lymphocytes from patients with asthma in remission.
    Noma T; Sugawara Y; Ogawa N; Saeki T; Yamaguchi K; Kawano Y
    Pediatr Allergy Immunol; 2004 Oct; 15(5):459-68. PubMed ID: 15482523
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developmental regulation of IL-4, IL-2, and IFN-gamma production by murine peripheral T lymphocytes.
    Adkins B; Ghanei A; Hamilton K
    J Immunol; 1993 Dec; 151(12):6617-26. PubMed ID: 7903095
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Enhanced gamma interferon production through activation of Valpha14(+) natural killer T cells by alpha-galactosylceramide in interleukin-18-deficient mice with systemic cryptococcosis.
    Kawakami K; Kinjo Y; Yara S; Uezu K; Koguchi Y; Tohyama M; Azuma M; Takeda K; Akira S; Saito A
    Infect Immun; 2001 Nov; 69(11):6643-50. PubMed ID: 11598033
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The relationship between immune interferon production and proliferation in antigen-specific, MHC-restricted T cell lines and clones.
    Hecht TT; Longo DL; Matis LA
    J Immunol; 1983 Sep; 131(3):1049-55. PubMed ID: 6193170
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.